This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

November 4–6, 2024Stockholm, Sweden

Daniel Forler
Director Business Development at Bayer Pharmaceuticals


Dr. Daniel Forler is Senior Director for Business Development, Licensing & Open Innovation at Bayer Pharmaceuticals Division focusing on in- and out-licensing deals with academic and biotech companies.

He is involved in the establishment of the Cell & Gene Therapy Translation Centre in Berlin, which is built together with the state/city of Berlin and Charité/BIH and brings 10 years+ of experiences in Business Development. This is including three years in Boston to represent Bayer`s Early Licensing Group in the US and several years in Strategic Alliance Management in Berlin, Germany with responsibility for several oncological partnerships and Bayer`s biomarker collaborations across all indications (Oncology and Cardiovascular diseases).

Prior Joining BD, he acted as laboratory head at Bayer in target discovery and validation mainly for Oncology, completed his PostDoc at Schering AG and did his PhD in biochemistry at the European Molecular Biology Laboratory (EMBL) in Heidelberg. Daniel studied biology in Freiburg, Leeds and Vancouver.

Agenda Sessions

  • The cell & gene therapy frontier: partnerships, progress, and prospects